CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -18.2% ·
Aktienfluss -9.2% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -1 | 71.70M | $2.68B | +5 | −6 |
| Q1 2026 | 93 | +2 | 73.05M | $2.65B | +9 | −7 |
| Q4 2025 | 90 | 0 | 75.54M | $3.52B | — | — |
| Q3 2025 | 15 | 0 | 56.94M | $2.37B | — | — |
| Q2 2025 | 12 | 0 | 51.44M | $1.48B | +1 | −1 |
| Q1 2025 | 9 | -2 | 19.08M | $640.10M | +2 | −4 |
| Q4 2024 | 11 | -1 | 21.01M | $1.07B | — | −1 |
| Q3 2024 | 11 | -2 | 14.60M | $745.98M | — | −2 |
| Q2 2024 | 13 | — | 14.80M | $663.11M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.89M | -0.8% | $231.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 5.11M | -5.6% | $171.47M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 5.11M | -5.6% | $171.47M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passiv) | 3.28M | +9.8% | $110.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 2.19M | +4.4% | $73.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 2.19M | +4.4% | $73.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 778.40K | -72.1% | $26.11M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 773.35K | +38.3% | $25.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 38.55K | +716.4% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 38.55K | +716.4% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Marshall Wace ✦ | 9.18K | Neu | $307,964 | 0.0% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 6.69K | Neu | $224,316 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $307,964 | 0.0% |
| Millennium Management | $224,316 | 0.0% |
Ausgestiegen
| Duquesne Family Office | $6.27M | war 0.2% |
| Adage Capital Partners | $3.32M | war 0.0% |
| D. E. Shaw & Co. | $504,960 | war 0.0% |
| AQR Capital Management | $398,712 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 241 Inhaber, 121.45M Anteile, $4.08B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.